Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery

NCT01101139 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: Sugammadex
DRUG: Placebo

Sponsor

Technical University of Munich